查詢結果分析
來源資料
頁籤選單縮合
題 名 | 造血幹細胞移植的演進=The Developments in Hematopoietic Stem Cells Transplantation |
---|---|
作 者 | 王玉祥; | 書刊名 | 內科學誌 |
卷 期 | 10:2 1999.04[民88.04] |
頁 次 | 頁58-65 |
分類號 | 416.175 |
關鍵詞 | 造血幹細胞移植; 骨髓移植; 周邊血幹細胞移植; 臍帶血移植; Hematopoietic stem cell transplantation; Bone marrow transplantation; Peripheral blood stem cell transplantation; Cord blood transplantation; |
語 文 | 中文(Chinese) |
中文摘要 | 造血幹細胞移植臨床應用已卅載,已分別發展成為骨髓移植,周邊血幹細胞移植 及臍帶血移植,治療適應症亦自血液疾病,先天性血色素病變及遺傳性免疫不全等疾病,擴 展至抗癌治療與基因治療,此部份目前雖仍屬實驗階段,但已足以端倪出其美好遠景。骨髓 移植最常見的三大障礙…接種失敗,接種物對抗宿主疾病及高復發率,亦由於周邊血幹細胞 及臍帶血移植的演進,得以獲得部份解決。尢其周邊血幹細胞移植有恢復期短及接種物對抗 宿主疾病發生率低等優點,已確定將成為造血幹細胞移植的主流。臍帶血移植是一待發掘的 寶藏,它解決了幹細胞來源短缺的問題,但如何成功適用於成年患者是其未來發展的重點讓 我們拭目以待。 |
英文摘要 | Hematopoletic stem cell transplantation developed clinically 30 years ago. Currently, bone marrow is not the only source for stem cells harvesting. Peripheral blood stem cell transplantation and cord blood transplantation were performed successfully in 1985 and 1988 respectively. In addition to the management of hematologic disease and hereditary metabolic disorder, hematopoietic stem cell transplantation are crucially important in the field of anticancer treatment and gene therapy. Initially, graft failure, graft versus host disease and recurrence of underlying illness were three major problems in bone marrow transplantation. The advantages of PBSCT and CBT are helpful for solving these troubles through specific immunologic mechanisms. Further efforts into the studies of CBT should allow the development of effective transplantation for the most adult patients. |
本系統中英文摘要資訊取自各篇刊載內容。